Contact
searchSearch
HMP Global
Login

September/October 2025

Letter from the Editor
Celebrating a Decade of Innovation: Insights from CPC+CBEx and New Directions in Oncology Care
10/15/2025
Winston Wong, PharmD
In this issue, Editor-in-Chief Winston Wong, PharmD, shares highlights from CPC+CBEx 2025, showcasing groundbreaking research, innovative abstracts, and new strategies advancing value-driven, evidence-based oncology care.
In this issue, Editor-in-Chief Winston Wong, PharmD, shares highlights from CPC+CBEx 2025, showcasing groundbreaking research, innovative abstracts, and new strategies advancing value-driven, evidence-based oncology care.
In this issue, Editor-in-Chief...
10/15/2025
Journal of Clinical Pathways
ONLINE EXCLUSIVES
Virtual Screening Programs Expand Access to Cancer Screening Nationwide
10/15/2025
Grace Taylor, MS, MA
Virtual, community-based cancer screening programs significantly improve access to early detection services, especially in underserved populations, according to a study presented at the ASCO Annual Meeting.
Virtual, community-based cancer screening programs significantly improve access to early detection services, especially in underserved populations, according to a study presented at the ASCO Annual Meeting.
Virtual, community-based cancer...
10/15/2025
Journal of Clinical Pathways
ONLINE EXCLUSIVES
Progression-Free Survival in NSCLC: Clinical Utility, Limitations, and Evolving Standards
10/15/2025
Rajat Thawani, MD
Rajat Thawani, MD, shares key insights on balancing progression-free and overall survival, the expanding role of biomarker testing, and the promise of multi-omic data integration in reshaping NSCLC treatment.
Rajat Thawani, MD, shares key insights on balancing progression-free and overall survival, the expanding role of biomarker testing, and the promise of multi-omic data integration in reshaping NSCLC treatment.
Rajat Thawani, MD, shares key...
10/15/2025
Journal of Clinical Pathways
Transformative Employer Trends
Employers and Manufacturers: A Call to Action to Co-Lead the Future of Health Care
10/15/2025
F. Randy Vogenberg, PhD, FASHP
As unprecedented medical and technological advances outpace existing care and reimbursement models, employers and manufacturers must collaborate through data-driven, trust-based frameworks to ensure equitable access to care.
As unprecedented medical and technological advances outpace existing care and reimbursement models, employers and manufacturers must collaborate through data-driven, trust-based frameworks to ensure equitable access to care.
As unprecedented medical and...
10/15/2025
Journal of Clinical Pathways
COA Viewpoint
Will CMS Fix the IRA for Community Oncology Before It’s Too Late?
10/15/2025
Nicolas Ferreyros
Congress’s effort to lower drug prices through the Inflation Reduction Act may have unintended—and potentially devastating—consequences for community oncology practices, threatening access and affordability for the majority of Americans...
Congress’s effort to lower drug prices through the Inflation Reduction Act may have unintended—and potentially devastating—consequences for community oncology practices, threatening access and affordability for the majority of Americans...
Congress’s effort to lower drug...
10/15/2025
Journal of Clinical Pathways
Transformative Business Trends
Employer-Driven Health Care: Opportunities for Change
10/15/2025
F. Randy Vogenberg, PhD, FASHP
As government reforms and market pressures reshape the health insurance landscape, this column explores how employers, manufacturers, and policymakers must realign their strategies to bridge transparency gaps, manage rising costs, and sustain...
As government reforms and market pressures reshape the health insurance landscape, this column explores how employers, manufacturers, and policymakers must realign their strategies to bridge transparency gaps, manage rising costs, and sustain...
As government reforms and market...
10/15/2025
Journal of Clinical Pathways
Original Research
Standardizing Somatic and Germline Molecular Testing in Prostate Cancer: Care Pathway and EHR Applications
10/15/2025
Mehmet Asim Bilen, MD; Aleksandar Zafirovski, MBA; Robert A. Bailey, MD; Ibrahim Khilfeh, PharmD; Urmi Bapat, MD; Kyra Svoboda, BS; Michael Kramer, MD, MBA
This study presents the development of an evidence-informed care pathway and EHR-integrated tools to standardize tumor and germline testing workflows for patients with metastatic prostate cancer.
This study presents the development of an evidence-informed care pathway and EHR-integrated tools to standardize tumor and germline testing workflows for patients with metastatic prostate cancer.
This study presents the...
10/15/2025
Journal of Clinical Pathways
ONLINE EXCLUSIVES
CPC+CBEx Abstracts
10/15/2025
For this year's Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx), authors contributed research that presented real-world evidence, conceptual models, and proposals designed to inform the development and refinement of...
For this year's Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx), authors contributed research that presented real-world evidence, conceptual models, and proposals designed to inform the development and refinement of...
For this year's Clinical...
10/15/2025
Journal of Clinical Pathways
Original Research
Real-World Outcomes of Next-Generation Sequencing of Progressive Radioactive Iodine Refractory Metastatic Thyroid Cancer and Treatment of These Patients With Redifferentiation Protocol
10/15/2025
Jennifer Wheeley, MS, FNP-C; Nikita Chintapally, MD; Kanchan Kulkarni, MD; Gabriel Yohe, MS; Priya Kundra, MD; Jennifer Rosen, MD; Muhammad M. Shaikh, MD; Meeta Sharma, MD; Jason Wexler, MD; Kenneth D. Burman, MD; Leila Shobab, MD; Irina Veytsman, MD
In this study, targeted redifferentiation with BRAF and MEK inhibition restored radioactive iodine avidity in the majority of patients with refractory differentiated thyroid cancer, highlighting a promising therapeutic approach.
In this study, targeted redifferentiation with BRAF and MEK inhibition restored radioactive iodine avidity in the majority of patients with refractory differentiated thyroid cancer, highlighting a promising therapeutic approach.
In this study, targeted...
10/15/2025
Journal of Clinical Pathways
JCP Nov-Dec Cover

Current Issue

December 2025
Volume 11
Issue 6
Current Issue
Issue Archive

Special Reports

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

October 2025 Volume 11 Issue 5

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use